VERMOX (Johnson & Johnson Consumer Inc, McNeil Consumer Healthcare Division)
Welcome to the PulseAid listing for the VERMOX drug offered from Johnson & Johnson Consumer Inc, McNeil Consumer Healthcare Division. This Antihelminthic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Johnson & Johnson Consumer Inc, McNeil Consumer Healthcare Division |
NON-PROPRIETARY NAME: | mebendazole |
SUBSTANCE NAME: | MEBENDAZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antihelminthic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, CHEWABLE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1975-01-14 |
END MARKETING DATE: | 0000-00-00 |
VERMOX HUMAN PRESCRIPTION DRUG Details:
Item Description | VERMOX from Johnson & Johnson Consumer Inc, McNeil Consumer Healthcare Division |
LABELER NAME: | Johnson & Johnson Consumer Inc, McNeil Consumer Healthcare Division |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 1975-01-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50580-070_3e39b5e3-d0de-4d0d-93a5-071198551c0e |
PRODUCT NDC: | 50580-070 |
APPLICATION NUMBER: | NDA017481 |
Other MEBENDAZOLE Pharmaceutical Manufacturers / Labelers: